Effects of chronic treatment with amino-oxyacetic acid or sodium n-dipropylacetate on brain GABA levels and the development and regression of cobalt epileptic foci in rats.
D000612:4-Aminobutyrate Transaminase / Q000378:metabolism; D000085:Acetates / Q000494:pharmacology*; D000613:Aminobutyrates / Q000378:metabolism*; D000625:Aminooxyacetic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002540:Cerebral Cortex / Q000201:enzymology; D003035:Cobalt / Q000494:pharmacology*; D004569:Electroencephalography; D005968:Glutamate Decarboxylase / Q000378:metabolism; D008297:Male; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D013997:Time Factors; D014631:Valerates / Q000494:pharmacology*; D014635:Valproic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D000085:Acetates; D000613:Aminobutyrates; D014631:Valerates; D000625:Aminooxyacetic Acid; D003035:Cobalt; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D000612:4-Aminobutyrate Transaminase; D005968:Glutamate Decarboxylase